Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar Rodriguez

Showing results (211-220 of 256) with videos related to

Pageof 26
Sort By:
Journal of Economic Entomology|March 17, 2022
Monitoring of Spotted-Wing Drosophila (Diptera: Drosophilidae) Resistance Status Using a RAPID Method for Assessing Insecticide Sensitivity Across the United StatesRufus Isaacs, Steven Van Timmeren, Brian E Gress, et al.
ACS Nano|May 9, 2020
Direct Visualization of Vesicle Disassembly and Reassembly Using Photocleavable Dendrimers Elucidates Cargo Release MechanismsShangda Li, Boao Xia, Bilal Javed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2025
Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapyZachary M Avigan, Jerrel Catlett, Saoirse Bodnar, et al.
British Journal of Haematology|March 20, 2024
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN studyAjay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, et al.
Blood Cancer Journal|April 14, 2022
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFINAjay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 23, 2025
Interventional strategies to address burnout in young medical oncologists: results from the Resilience-Spanish Society of Medical Oncology (SEOM) Study and a university hospital experience in SpainVilma Pacheco-Barcia, Berta Obispo, Elia Tomas, et al.
Blood Advances|August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myelomaTarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2019
Encoding biological recognition in a bicomponent cell-membrane mimicCesar Rodriguez-Emmenegger, Qi Xiao, Nina Yu Kostina, et al.
Ejhaem|July 18, 2022
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trialNoa Biran, Binod Dhakal, Suzanne Lentzsch, et al.
Blood Advances|September 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groupsUrvi A Shah, Erin Moshier, Andriy Derkach, et al.
Pageof 26

Showing results (211-220 of 256) with videos related to

Sort By:
Pageof 26
Journal of Economic Entomology|March 17, 2022
Monitoring of Spotted-Wing Drosophila (Diptera: Drosophilidae) Resistance Status Using a RAPID Method for Assessing Insecticide Sensitivity Across the United StatesRufus Isaacs, Steven Van Timmeren, Brian E Gress, et al.
ACS Nano|May 9, 2020
Direct Visualization of Vesicle Disassembly and Reassembly Using Photocleavable Dendrimers Elucidates Cargo Release MechanismsShangda Li, Boao Xia, Bilal Javed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2025
Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapyZachary M Avigan, Jerrel Catlett, Saoirse Bodnar, et al.
British Journal of Haematology|March 20, 2024
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN studyAjay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, et al.
Blood Cancer Journal|April 14, 2022
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFINAjay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 23, 2025
Interventional strategies to address burnout in young medical oncologists: results from the Resilience-Spanish Society of Medical Oncology (SEOM) Study and a university hospital experience in SpainVilma Pacheco-Barcia, Berta Obispo, Elia Tomas, et al.
Blood Advances|August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myelomaTarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2019
Encoding biological recognition in a bicomponent cell-membrane mimicCesar Rodriguez-Emmenegger, Qi Xiao, Nina Yu Kostina, et al.
Ejhaem|July 18, 2022
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trialNoa Biran, Binod Dhakal, Suzanne Lentzsch, et al.
Blood Advances|September 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groupsUrvi A Shah, Erin Moshier, Andriy Derkach, et al.
Pageof 26